Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

mRNA COVID-19 vaccines may increase patients' concerns about side effects

mRNA COVID-19 vaccines may increase patients' concerns about side effects

Updated ACR position statement on patient safety and site of service for biologics released

Updated ACR position statement on patient safety and site of service for biologics released

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Scientists explain possible causes of anaphylaxis following mRNA COVID-19 vaccination

Scientists explain possible causes of anaphylaxis following mRNA COVID-19 vaccination

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

People with venom allergies are more likely to have bone marrow disorder

People with venom allergies are more likely to have bone marrow disorder

FDA expands emergency use authorization for Pfizer-BioNTech COVID-19 Vaccine

FDA expands emergency use authorization for Pfizer-BioNTech COVID-19 Vaccine

Changes to infant gut bacteria and food allergies are linked to C-section birth, ethnicity

Changes to infant gut bacteria and food allergies are linked to C-section birth, ethnicity

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

NIH-funded clinical trial begins study of systemic allergic reactions to COVID-19 vaccines

NIH-funded clinical trial begins study of systemic allergic reactions to COVID-19 vaccines

Study lists five facts to know about antihistamines

Study lists five facts to know about antihistamines

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

ChAdOx1 nCoV-19 offers less protection against South African SARS-CoV-2 variant

ChAdOx1 nCoV-19 offers less protection against South African SARS-CoV-2 variant

Study provides accurate data on allergic reactions related to mRNA COVID-19  vaccines

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

Study reveals new molecular mechanism linked to severe anaphylaxis

Study reveals new molecular mechanism linked to severe anaphylaxis

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Novel immunotherapy approach to revert the main hallmarks of cat allergy

Novel immunotherapy approach to revert the main hallmarks of cat allergy